A protein-building molecule helped switch resistant prostate tumors back into a drug-sensitive state in experimental models, offering a potential target for future treatments. Many treatments for prostate cancer, one of the most common cancers in men, target a protein called the androgen receptor, which fuels tumor growth. Tumors can escape that approach by becoming less […]